Navigation Links
Homeopathic Pharmacists Association Highlights the Extraordinary Safety Record of Homeopathic Medicines

MILWAUKIE, Ore., July 23 /PRNewswire/ -- While the causal relationship between intranasal zinc preparations and anosmia is examined in a new study published in the July issue of Archives of Otolaryngology-Head & Neck Surgery, the study's practical application on public health is reduced to supporting action taken last summer by the U.S. Food and Drug Administration (FDA) in removing related products from the marketplace.

Contrary to the position taken by Terrance M. Davidson, M.D., and Wendy M. Smith, M.D. in their recently published study, "The Bradford Hill Criteria and Zinc-Induced Anosmia," action by the FDA against products containing intranasal zinc gluconate demonstrates the agency's competency in regulating homeopathic medicines to protect the public's health. Drs. Davidson and Smith of the University of California evaluated 25 patients who apparently developed anosmia after using intranasal zinc gluconate, as well as reports of clinical, biological and experimental data. Beyond showing that zinc was the causative agent, Davidson and Smith then presumed that the system needs strengthening rather than acknowledging its success last summer. In fact, the FDA had monitored the reported cases of claimed zinc-induced anosmia and took appropriate action in a judicious manner—an action supported by the American Association of Homeopathic Pharmacists to protect public health.

Homeopathic medications are regulated by the FDA and have been used safely in the United States since before the passage of the Federal Food, Drug, and Cosmetic Act in 1938. Homeopathic medicines have an extraordinary record of safety. FDA's Compliance Policy Guide (CPG 7132.15) "Conditions Under Which Homeopathic Drugs May Be Marketed" has been an effective and workable way to regulate homeopathic drugs since 1988.

To learn more about the regulatory process and the association's work to better the understanding and appreciation of homeopathic medicines by both professionals and consumers, visit

About the AAHP

Founded in 1923, the AAHP is a not-for-profit corporation of the State Commonwealth of Virginia, representing the interests of homeopathic manufacturers, distributors, and individual pharmacists in cooperative efforts with regulatory agencies and other organizations nationally.

The AAHP functions as a trade association within the homeopathic pharmaceutical industry to represent the opinions and interests of homeopathic product manufacturers and distributors, to the FDA, other regulatory agencies and other trade associations. In addition, the association promotes high standards in manufacturing and distributing, communicates regulatory changes to member companies through a regular newsletter and promotes professional communication, education, and research within the homeopathic community.

SOURCE American Association of Homeopathic Pharmacists
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Confusion over Influenzinum Clarified by the American Association of Homeopathic Pharmacists (AAHP)
2. Confusion Over Homeopathic Medicines in Alexa Ray Joels Hospitalization Clarified by the American Association of Homeopathic Pharmacists (AAHP)
3. CVS Caremark Celebrates Outstanding Pharmacy Care to Patients During American Pharmacists Month in October
4. National Pharmacy Technician Day: Pharmacy Technician Certification Board (PTCB) Recognizes Pharmacy Technicians During Octobers American Pharmacists Month
5. Pharmacists Report Patients do not Treat Cold and Flu Symptoms Early Enough, New Survey Shows
6. Pharmacists Work with Congress to Address PBM Abuses
7. Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th
8. New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting
9. Thomson Reuters Launches Pharmacy Intervention Solution for Hospital Pharmacists
10. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
11. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
Post Your Comments:
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Marker Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
(Date:11/25/2015)... 2015  The American Academy of Pediatrics (AAP), ... the March of Dimes cheered today,s signature into ... Act of 2015 (S.799), which takes much-needed ... exposed to drugs, such as opioids, and to ... three organizations have worked together leading advocacy efforts ...
(Date:11/25/2015)... 2015  ARKRAY USA , Inc., ... evidence demonstrating the accuracy of its blood glucose meter ... Resistance, Diabetes and Cardiovascular Disease in Los ... GLUCOCARD ® 01 meter and the Assure ® ... ability to accurately measure glucose levels in blood is ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, ... to dispense prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. ... dispense prescription medications. In doing so, it could help to prevent potential overdose ...
(Date:11/27/2015)... ... ... No.1 Herpes-only dating community in the world, revealed that over 50% of its members are ... people under the age of 50 – or 67% of the population - are infected ... HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping ... platform for mental health and wellness consultation, has collaborated with a leading web-based ... the knowledge gap experienced by parents and bring advice from parenting experts within ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... contact center software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term ... fully supported Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug ... need to integrate dose form selection in early phase drug development. The first ... supporting and bringing together the UK’s emerging life sciences companies, corporate partners, and ...
Breaking Medicine News(10 mins):